Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review

Helicobacter pylori (H. pylori) infection has become an emerging problem in Indonesia despite its relatively low prevalence as opposed to other Southeast Asian and Asian countries. Strains containing less virulent genotypes predominantly found in Indonesia is suggested to be the rationale for why th...

Full description

Saved in:
Bibliographic Details
Main Authors: Rizani Putri Iman, Tiroy Junita, Rinaldo Indra Rachman, Ari Fahrial Syam
Format: Article
Language:English
Published: Interna Publishing 2021-10-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:http://www.actamedindones.org/index.php/ijim/article/view/1265
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849721595098038272
author Rizani Putri Iman
Tiroy Junita
Rinaldo Indra Rachman
Ari Fahrial Syam
author_facet Rizani Putri Iman
Tiroy Junita
Rinaldo Indra Rachman
Ari Fahrial Syam
author_sort Rizani Putri Iman
collection DOAJ
description Helicobacter pylori (H. pylori) infection has become an emerging problem in Indonesia despite its relatively low prevalence as opposed to other Southeast Asian and Asian countries. Strains containing less virulent genotypes predominantly found in Indonesia is suggested to be the rationale for why the disease prevalence, as well as its gastric cancer complication, remain inferior in respect of neighboring counterparts. Although endoscopic evaluation is still necessary to determine the gastric mucosal status of those infected with H. pylori, the infection itself can be easily diagnosed with test-and-treat strategy especially in areas with limited resources. Several findings revealed high rates of antibiotic resistance varying among Indonesian regions and ethnicities, suggesting that triple therapy regimen may not be suitable for all population. Whereas treatment should be based on the pattern of resistance in respected region, novel regimens involving furazolidone, rifabutin, and sitafloxacin are proposed as potential drugs of choice to eradicate H. pylori infection. In order to determine the adequate approach for H. pylori infection in Indonesia, further multicenter studies involving larger sample size should be conducted.
format Article
id doaj-art-0949b7cd2ebc4c6f98f35e70f048db59
institution DOAJ
issn 0125-9326
2338-2732
language English
publishDate 2021-10-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj-art-0949b7cd2ebc4c6f98f35e70f048db592025-08-20T03:11:37ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322021-10-01533Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature ReviewRizani Putri Iman0Tiroy Junita1Rinaldo Indra Rachman2Ari Fahrial Syam3Faculty of Medicine Universitas Indonesia, Jakarta, IndonesiaFaculty of Medicine Universitas Indonesia, Jakarta, IndonesiaFaculty of Medicine Universitas Indonesia, Jakarta, IndonesiaDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Cipto Mangunkusumo Hospital, Jakarta, IndonesiaHelicobacter pylori (H. pylori) infection has become an emerging problem in Indonesia despite its relatively low prevalence as opposed to other Southeast Asian and Asian countries. Strains containing less virulent genotypes predominantly found in Indonesia is suggested to be the rationale for why the disease prevalence, as well as its gastric cancer complication, remain inferior in respect of neighboring counterparts. Although endoscopic evaluation is still necessary to determine the gastric mucosal status of those infected with H. pylori, the infection itself can be easily diagnosed with test-and-treat strategy especially in areas with limited resources. Several findings revealed high rates of antibiotic resistance varying among Indonesian regions and ethnicities, suggesting that triple therapy regimen may not be suitable for all population. Whereas treatment should be based on the pattern of resistance in respected region, novel regimens involving furazolidone, rifabutin, and sitafloxacin are proposed as potential drugs of choice to eradicate H. pylori infection. In order to determine the adequate approach for H. pylori infection in Indonesia, further multicenter studies involving larger sample size should be conducted.http://www.actamedindones.org/index.php/ijim/article/view/1265risk factordiagnosiscurrent treatmentHelicobacter pyloriinfection
spellingShingle Rizani Putri Iman
Tiroy Junita
Rinaldo Indra Rachman
Ari Fahrial Syam
Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review
Acta Medica Indonesiana
risk factor
diagnosis
current treatment
Helicobacter pylori
infection
title Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review
title_full Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review
title_fullStr Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review
title_full_unstemmed Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review
title_short Risk factor, diagnosis, and current treatment of H. pylori Infection in Indonesia: A Literature Review
title_sort risk factor diagnosis and current treatment of h pylori infection in indonesia a literature review
topic risk factor
diagnosis
current treatment
Helicobacter pylori
infection
url http://www.actamedindones.org/index.php/ijim/article/view/1265
work_keys_str_mv AT rizaniputriiman riskfactordiagnosisandcurrenttreatmentofhpyloriinfectioninindonesiaaliteraturereview
AT tiroyjunita riskfactordiagnosisandcurrenttreatmentofhpyloriinfectioninindonesiaaliteraturereview
AT rinaldoindrarachman riskfactordiagnosisandcurrenttreatmentofhpyloriinfectioninindonesiaaliteraturereview
AT arifahrialsyam riskfactordiagnosisandcurrenttreatmentofhpyloriinfectioninindonesiaaliteraturereview